Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helmut Butzkueven

Showing results (101-110 of 390) with videos related to

Pageof 39
Sort By:
Plos One|December 29, 2012
Optic nerve magnetisation transfer ratio after acute optic neuritis predicts axonal and visual outcomesYejun Wang, Anneke van der Walt, Mark Paine, et al.
BMJ Open|October 21, 2020
Natalizumab versus fingolimod for patients with active relapsing-remitting multiple sclerosis: results from REVEAL, a prospective, randomised head-to-head studyHelmut Butzkueven, Stephanie Licata, Douglas Jeffery, et al.
Multiple Sclerosis and Related Disorders|January 27, 2022
Quantifying the impact of upper limb tremor on the quality of life of people with multiple sclerosis: a comparison between the QUEST and MSIS-29 scalesChi-Chang Tang, Sze-Ee Soh, Frederique Boonstra, et al.
Autoimmunity Reviews|July 15, 2022
Psychiatric manifestations of autoimmune encephalitisHannah Ford, Sarah Griffith, Nicola Warren, et al.
BMJ Neurology Open|January 25, 2024
Monash-Alfred protocol for assessment of atypical parkinsonian syndromes (MAP-APS)Timothy P Siejka, Kelly L Bertram, Huiliang M Tang, et al.
Scientific Reports|January 16, 2024
Transcriptomics identifies blunted immunomodulatory effects of vitamin D in people with multiple sclerosisWei Z Yeh, Rodney Lea, Jim Stankovich, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 15, 2020
Clinical outcomes in patients who discontinue natalizumab therapy after 2 years in the Tysabri<sup>®</sup> Observational Program (TOP)Helmut Butzkueven, Maria Trojano, Ludwig Kappos, et al.
Multiple Sclerosis and Related Disorders|February 27, 2026
Chronic lesion expansion as an imaging biomarker in multiple sclerosisMichael T G Hayes, Heidi N Beadnall, Daniel Merlo, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 4, 2017
Tremor in multiple sclerosis is associated with cerebello-thalamic pathologyFrederique Boonstra, Grace Florescu, Andrew Evans, et al.
Multiple Sclerosis and Related Disorders|September 20, 2016
Brain health: time matters in multiple sclerosisGavin Giovannoni, Helmut Butzkueven, Suhayl Dhib-Jalbut, et al.
Pageof 39

Showing results (101-110 of 390) with videos related to

Sort By:
Pageof 39
Plos One|December 29, 2012
Optic nerve magnetisation transfer ratio after acute optic neuritis predicts axonal and visual outcomesYejun Wang, Anneke van der Walt, Mark Paine, et al.
BMJ Open|October 21, 2020
Natalizumab versus fingolimod for patients with active relapsing-remitting multiple sclerosis: results from REVEAL, a prospective, randomised head-to-head studyHelmut Butzkueven, Stephanie Licata, Douglas Jeffery, et al.
Multiple Sclerosis and Related Disorders|January 27, 2022
Quantifying the impact of upper limb tremor on the quality of life of people with multiple sclerosis: a comparison between the QUEST and MSIS-29 scalesChi-Chang Tang, Sze-Ee Soh, Frederique Boonstra, et al.
Autoimmunity Reviews|July 15, 2022
Psychiatric manifestations of autoimmune encephalitisHannah Ford, Sarah Griffith, Nicola Warren, et al.
BMJ Neurology Open|January 25, 2024
Monash-Alfred protocol for assessment of atypical parkinsonian syndromes (MAP-APS)Timothy P Siejka, Kelly L Bertram, Huiliang M Tang, et al.
Scientific Reports|January 16, 2024
Transcriptomics identifies blunted immunomodulatory effects of vitamin D in people with multiple sclerosisWei Z Yeh, Rodney Lea, Jim Stankovich, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 15, 2020
Clinical outcomes in patients who discontinue natalizumab therapy after 2 years in the Tysabri<sup>®</sup> Observational Program (TOP)Helmut Butzkueven, Maria Trojano, Ludwig Kappos, et al.
Multiple Sclerosis and Related Disorders|February 27, 2026
Chronic lesion expansion as an imaging biomarker in multiple sclerosisMichael T G Hayes, Heidi N Beadnall, Daniel Merlo, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 4, 2017
Tremor in multiple sclerosis is associated with cerebello-thalamic pathologyFrederique Boonstra, Grace Florescu, Andrew Evans, et al.
Multiple Sclerosis and Related Disorders|September 20, 2016
Brain health: time matters in multiple sclerosisGavin Giovannoni, Helmut Butzkueven, Suhayl Dhib-Jalbut, et al.
Pageof 39